Medication for the treatment of alcohol use disorder: a brief guide
- Series Title(s):
- DHHS publication
- Contributor(s):
- Center for Substance Abuse Treatment (U.S.). Division of Pharmacologic Therapies, issuing body. JBS International (Firm), issuing body.
- Publication:
- Rockville, MD : U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies, 2015
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Alcohol-Related Disorders -- drug therapy Disulfiram -- therapeutic use Naltrexone -- therapeutic use Taurine -- therapeutic use
- Abstract:
- Medication-assisted treatment has shown much promise in reducing alcohol use and promoting abstinence in patients diagnosed with alcohol use disorder. Considerable research evidence and consensus among experts support the use of pharmacologic treatments in primary care settings. A number of FDA-approved medications have been shown to be important elements of such treatment. Although some patients do not benefit from medication-assisted treatment, most do. For each patient deemed an appropriate candidate for medication-assisted treatment, multiple pharmacologic agents offer a variety of options so that treatment can be tailored to each patient's needs and circumstances. As a new patient care models are encouraged by the Patient Protection and Affordable Care Act and the accompanying improvements in the quality and quantity of treatment options that are anticipated as the ACA is implemented, there is considerable potential for expanding the use of medication-assisted treatment as clinicians recognize their safety, efficacy, and cost-effectiveness.
- Copyright:
- The National Library of Medicine believes this item to be in the public domain (More information)
- Extent:
- 1 online resource (1 PDF file (ii, 34 pages)).
- NLM Unique ID:
- 101672700 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101672700